secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001193125-25-137032
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics shareholders approve doubling authorized shares to 400M, elect new director
--------------------------------------------------------------------------------

- Shareholders approved amendment to increase authorized common stock from 200M to 400M shares (85.8M for, 11M against).
- Lesley Ann Calhoun elected as Class I director with 73.1M votes for, 10.5M withheld.
- Ratification of PricewaterhouseCoopers as auditor for FY2025 passed with 96.7M for.
- Non-binding say-on-pay passed; annual advisory vote frequency approved (73M votes for one year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525137032/0001193125-25-137032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000119312525137032/d926935d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-137032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer